Omar Ali, PhD dark+linkedin

Partner

Omar Ali is a Partner at Awaken Capital and an inventor and founder of multiple cell-programming platforms that have been acquired or in-licensed by large biotech and pharmaceutical companies. Omar recently co-founded Immulus and served as CEO where he led the company’s validation of products that could enhance the performance of cell therapies, partnerships and acquisition by Lyell Immunopharma in 2020.  Prior to founding Immulus, Omar was a Scientist at the Wyss Institute for Biologically Inspired Engineering where he directed the discovery and clinical translation of early-stage biotechnologies. Omar earned a PhD in Bioengineering from Harvard, an MBA from Babson Graduate School of Business, a master’s degree in bioengineering from the University of Michigan, and a bachelor’s degree in chemical engineering from the University of Minnesota.